ORUM

KQ:475830 Korea Biotechnology
Market Cap
$788.06K
₩1.15 Billion KRW
Market Cap Rank
#36644 Global
#2146 in Korea
Share Price
₩121500.00
Change (1 day)
-7.32%
52-Week Range
₩17010.00 - ₩143700.00
All Time High
₩143700.00
Categories
Companies in Korea Biotechnology
About

Orum Therapeutics, Inc., a biopharmaceutical company, engages in the research and development of pharmaceuticals for cancer and immune diseases. The company develops BMS-986497 (ORM-6151), which is in phase 1 clinical trial to treat acuta myeloid leukemia and high-risk myelodysplastic syndromes; ORM-1153, which is in preclinical trial to treat acuta myeloid leukemia and heme-onc; and ORM-1023, wh… Read more

ORUM (475830) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of March 2025: -0.045x

Based on the latest financial reports, ORUM (475830) has a cash flow conversion efficiency ratio of -0.045x as of March 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-7.31 Billion) by net assets (₩161.79 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

ORUM - Cash Flow Conversion Efficiency Trend (2022–2024)

This chart illustrates how ORUM's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

ORUM Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ORUM ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Sileon AB
ST:SILEON
 		-0.285x
Omkar Speciality Chemicals Limited
NSE:OMKARCHEM
 		-0.005x
Northgold AB
ST:NG
 		-0.044x
Next Mediaworks Limited
NSE:NEXTMEDIA
 		0.011x
Trucept Inc
PINK:TREP
 		-1.486x
DriveItAway Inc
PINK:DWAY
 		0.025x
Totalindo Eka Persada Tbk PT
JK:TOPS
 		-0.009x
Rapid Nutrition PLC
PINK:RPNRF
 		-1.217x

Annual Cash Flow Conversion Efficiency for ORUM (2022–2024)

The table below shows the annual cash flow conversion efficiency of ORUM from 2022 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩121.76 Billion ₩-11.28 Billion -0.093x +94.48%
2023-12-31 ₩-56.18 Billion ₩94.24 Billion -1.678x -620.35%
2022-12-31 ₩-127.46 Billion ₩-41.09 Billion 0.322x --